Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 35/4 NEXThaler versus free beclometasone dipropionate plus formoterol in asthmatic children
2015-005152-10Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of beclometasone dipropionate + formoterol, beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Plasma AUC(0-t) for B17MP. Started Jan 2016; status: completed.
02
Drugs
beclometasone dipropionate + formoterolbeclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-005152-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005152-10.